Figure 7 | Scientific Reports

Figure 7

From: Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies

Figure 7

Bar graph presentation showing the percentage of cells (Y-axis) in the sub-G1, G1, S, and G2 phases of the cell cycle after the DMSO (control solvent)/BPU (target agent) treatments to evaluate the effect of the explored compound BPU (5, 10, and 20 µM concentrations, respectively) on cell cycle progression in Jurkat cells (after 48 h of treatment). The data shown were obtained from two independent experiments (at least) and error bars have been indicated.

Back to article page